IL1B and fatty liver disease: Numerous studies [29, 30] have demonstrated that IL-1β expedites ALD progression by amplifying the production of pro-inflammatory cytokines, upregulating fatty acid synthesis, inducing liver steatosis, and promoting liver fibrosis.